世界の色素沈着障害治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Pigmentation Disorder Therapeutic Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4618 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、色素沈着障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法（外用薬、ハイドロキノン、L-アスコルビン酸など）、美容治療（ケミカルピーリング、レーザー治療、植皮など））、用途別市場規模（皮膚科クリニック、ドラッグストア、化粧品店、エステティッククリニック、Eコマース、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・色素沈着障害治療の市場動向 ・企業の競争状況、市場シェア ・色素沈着障害治療の種類別市場規模（薬物療法（外用薬、ハイドロキノン、L-アスコルビン酸など）、美容治療（ケミカルピーリング、レーザー治療、植皮など）） ・色素沈着障害治療の用途別市場規模（皮膚科クリニック、ドラッグストア、化粧品店、エステティッククリニック、Eコマース、その他） ・色素沈着障害治療の北米市場規模2016-2027（アメリカ、カナダ） ・色素沈着障害治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・色素沈着障害治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・色素沈着障害治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・色素沈着障害治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bayer、Allergan、Episciences、La Roche-Posay、SkinCeuticals、Pierre Fabre、Alvogen、Obagi） ・結論

Skin pigmentation refers to a skin disorder that causes either lightening of skin or darkening of skin when compared to the existing skin color.
Pigmentation therapies can be classified as topical drugs, microdermabrasion, chemical peels, phototherapy, and laser therapy. These therapies are available in hospitals and aesthetic clinics & dermatology centers.

Market Analysis and Insights: Global Pigmentation Disorder Therapeutic Market
The global Pigmentation Disorder Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pigmentation Disorder Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pigmentation Disorder Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pigmentation Disorder Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pigmentation Disorder Therapeutic market.

Global Pigmentation Disorder Therapeutic Scope and Market Size
Pigmentation Disorder Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pigmentation Disorder Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Pharmacological Treatment (Topical Drugs, Hydroquinone, L-Ascorbic Acid, etc.)
Cosmetic Treatment (Chemical Peel, Laser Therapy, Skin Grafting, etc.)

Segment by Application
Dermatology Clinics
Drugstores and Cosmetic Stores
Aesthetic Clinics
E-commerce
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer
Allergan
Episciences
La Roche-Posay
SkinCeuticals
Pierre Fabre
Alvogen
Obagi

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pigmentation Disorder Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pharmacological Treatment (Topical Drugs, Hydroquinone, L-Ascorbic Acid, etc.)
1.2.3 Cosmetic Treatment (Chemical Peel, Laser Therapy, Skin Grafting, etc.)
1.3 Market by Application
1.3.1 Global Pigmentation Disorder Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Dermatology Clinics
1.3.3 Drugstores and Cosmetic Stores
1.3.4 Aesthetic Clinics
1.3.5 E-commerce
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pigmentation Disorder Therapeutic Market Perspective (2016-2027)
2.2 Pigmentation Disorder Therapeutic Growth Trends by Regions
2.2.1 Pigmentation Disorder Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pigmentation Disorder Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 Pigmentation Disorder Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 Pigmentation Disorder Therapeutic Industry Dynamic
2.3.1 Pigmentation Disorder Therapeutic Market Trends
2.3.2 Pigmentation Disorder Therapeutic Market Drivers
2.3.3 Pigmentation Disorder Therapeutic Market Challenges
2.3.4 Pigmentation Disorder Therapeutic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pigmentation Disorder Therapeutic Players by Revenue
3.1.1 Global Top Pigmentation Disorder Therapeutic Players by Revenue (2016-2021)
3.1.2 Global Pigmentation Disorder Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global Pigmentation Disorder Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pigmentation Disorder Therapeutic Revenue
3.4 Global Pigmentation Disorder Therapeutic Market Concentration Ratio
3.4.1 Global Pigmentation Disorder Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pigmentation Disorder Therapeutic Revenue in 2020
3.5 Pigmentation Disorder Therapeutic Key Players Head office and Area Served
3.6 Key Players Pigmentation Disorder Therapeutic Product Solution and Service
3.7 Date of Enter into Pigmentation Disorder Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pigmentation Disorder Therapeutic Breakdown Data by Type
4.1 Global Pigmentation Disorder Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global Pigmentation Disorder Therapeutic Forecasted Market Size by Type (2022-2027)

5 Pigmentation Disorder Therapeutic Breakdown Data by Application
5.1 Global Pigmentation Disorder Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global Pigmentation Disorder Therapeutic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pigmentation Disorder Therapeutic Market Size (2016-2027)
6.2 North America Pigmentation Disorder Therapeutic Market Size by Type
6.2.1 North America Pigmentation Disorder Therapeutic Market Size by Type (2016-2021)
6.2.2 North America Pigmentation Disorder Therapeutic Market Size by Type (2022-2027)
6.2.3 North America Pigmentation Disorder Therapeutic Market Size by Type (2016-2027)
6.3 North America Pigmentation Disorder Therapeutic Market Size by Application
6.3.1 North America Pigmentation Disorder Therapeutic Market Size by Application (2016-2021)
6.3.2 North America Pigmentation Disorder Therapeutic Market Size by Application (2022-2027)
6.3.3 North America Pigmentation Disorder Therapeutic Market Size by Application (2016-2027)
6.4 North America Pigmentation Disorder Therapeutic Market Size by Country
6.4.1 North America Pigmentation Disorder Therapeutic Market Size by Country (2016-2021)
6.4.2 North America Pigmentation Disorder Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Pigmentation Disorder Therapeutic Market Size (2016-2027)
7.2 Europe Pigmentation Disorder Therapeutic Market Size by Type
7.2.1 Europe Pigmentation Disorder Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe Pigmentation Disorder Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe Pigmentation Disorder Therapeutic Market Size by Type (2016-2027)
7.3 Europe Pigmentation Disorder Therapeutic Market Size by Application
7.3.1 Europe Pigmentation Disorder Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe Pigmentation Disorder Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe Pigmentation Disorder Therapeutic Market Size by Application (2016-2027)
7.4 Europe Pigmentation Disorder Therapeutic Market Size by Country
7.4.1 Europe Pigmentation Disorder Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe Pigmentation Disorder Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pigmentation Disorder Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Type
8.2.1 Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Application
8.3.1 Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Region
8.4.1 Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pigmentation Disorder Therapeutic Market Size (2016-2027)
9.2 Latin America Pigmentation Disorder Therapeutic Market Size by Type
9.2.1 Latin America Pigmentation Disorder Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America Pigmentation Disorder Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America Pigmentation Disorder Therapeutic Market Size by Type (2016-2027)
9.3 Latin America Pigmentation Disorder Therapeutic Market Size by Application
9.3.1 Latin America Pigmentation Disorder Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America Pigmentation Disorder Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America Pigmentation Disorder Therapeutic Market Size by Application (2016-2027)
9.4 Latin America Pigmentation Disorder Therapeutic Market Size by Country
9.4.1 Latin America Pigmentation Disorder Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America Pigmentation Disorder Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pigmentation Disorder Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Type
10.2.1 Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Application
10.3.1 Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Country
10.4.1 Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Pigmentation Disorder Therapeutic Introduction
11.1.4 Bayer Revenue in Pigmentation Disorder Therapeutic Business (2016-2021)
11.1.5 Bayer Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Pigmentation Disorder Therapeutic Introduction
11.2.4 Allergan Revenue in Pigmentation Disorder Therapeutic Business (2016-2021)
11.2.5 Allergan Recent Development
11.3 Episciences
11.3.1 Episciences Company Details
11.3.2 Episciences Business Overview
11.3.3 Episciences Pigmentation Disorder Therapeutic Introduction
11.3.4 Episciences Revenue in Pigmentation Disorder Therapeutic Business (2016-2021)
11.3.5 Episciences Recent Development
11.4 La Roche-Posay
11.4.1 La Roche-Posay Company Details
11.4.2 La Roche-Posay Business Overview
11.4.3 La Roche-Posay Pigmentation Disorder Therapeutic Introduction
11.4.4 La Roche-Posay Revenue in Pigmentation Disorder Therapeutic Business (2016-2021)
11.4.5 La Roche-Posay Recent Development
11.5 SkinCeuticals
11.5.1 SkinCeuticals Company Details
11.5.2 SkinCeuticals Business Overview
11.5.3 SkinCeuticals Pigmentation Disorder Therapeutic Introduction
11.5.4 SkinCeuticals Revenue in Pigmentation Disorder Therapeutic Business (2016-2021)
11.5.5 SkinCeuticals Recent Development
11.6 Pierre Fabre
11.6.1 Pierre Fabre Company Details
11.6.2 Pierre Fabre Business Overview
11.6.3 Pierre Fabre Pigmentation Disorder Therapeutic Introduction
11.6.4 Pierre Fabre Revenue in Pigmentation Disorder Therapeutic Business (2016-2021)
11.6.5 Pierre Fabre Recent Development
11.7 Alvogen
11.7.1 Alvogen Company Details
11.7.2 Alvogen Business Overview
11.7.3 Alvogen Pigmentation Disorder Therapeutic Introduction
11.7.4 Alvogen Revenue in Pigmentation Disorder Therapeutic Business (2016-2021)
11.7.5 Alvogen Recent Development
11.8 Obagi
11.8.1 Obagi Company Details
11.8.2 Obagi Business Overview
11.8.3 Obagi Pigmentation Disorder Therapeutic Introduction
11.8.4 Obagi Revenue in Pigmentation Disorder Therapeutic Business (2016-2021)
11.8.5 Obagi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pigmentation Disorder Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pharmacological Treatment (Topical Drugs, Hydroquinone, L-Ascorbic Acid, etc.)
Table 3. Key Players of Cosmetic Treatment (Chemical Peel, Laser Therapy, Skin Grafting, etc.)
Table 4. Global Pigmentation Disorder Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Pigmentation Disorder Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pigmentation Disorder Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Pigmentation Disorder Therapeutic Market Share by Regions (2016-2021)
Table 8. Global Pigmentation Disorder Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Pigmentation Disorder Therapeutic Market Share by Regions (2022-2027)
Table 10. Pigmentation Disorder Therapeutic Market Trends
Table 11. Pigmentation Disorder Therapeutic Market Drivers
Table 12. Pigmentation Disorder Therapeutic Market Challenges
Table 13. Pigmentation Disorder Therapeutic Market Restraints
Table 14. Global Pigmentation Disorder Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Pigmentation Disorder Therapeutic Market Share by Players (2016-2021)
Table 16. Global Top Pigmentation Disorder Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pigmentation Disorder Therapeutic as of 2020)
Table 17. Ranking of Global Top Pigmentation Disorder Therapeutic Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Pigmentation Disorder Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pigmentation Disorder Therapeutic Product Solution and Service
Table 21. Date of Enter into Pigmentation Disorder Therapeutic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pigmentation Disorder Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Pigmentation Disorder Therapeutic Revenue Market Share by Type (2016-2021)
Table 25. Global Pigmentation Disorder Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Pigmentation Disorder Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Pigmentation Disorder Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Pigmentation Disorder Therapeutic Revenue Market Share by Application (2016-2021)
Table 29. Global Pigmentation Disorder Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Pigmentation Disorder Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Pigmentation Disorder Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Pigmentation Disorder Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Pigmentation Disorder Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Pigmentation Disorder Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Pigmentation Disorder Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Pigmentation Disorder Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Pigmentation Disorder Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Pigmentation Disorder Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Pigmentation Disorder Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Pigmentation Disorder Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Pigmentation Disorder Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Pigmentation Disorder Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Pigmentation Disorder Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Pigmentation Disorder Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Pigmentation Disorder Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Pigmentation Disorder Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Pigmentation Disorder Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Pigmentation Disorder Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 61. Bayer Company Details
Table 62. Bayer Business Overview
Table 63. Bayer Pigmentation Disorder Therapeutic Product
Table 64. Bayer Revenue in Pigmentation Disorder Therapeutic Business (2016-2021) & (US$ Million)
Table 65. Bayer Recent Development
Table 66. Allergan Company Details
Table 67. Allergan Business Overview
Table 68. Allergan Pigmentation Disorder Therapeutic Product
Table 69. Allergan Revenue in Pigmentation Disorder Therapeutic Business (2016-2021) & (US$ Million)
Table 70. Allergan Recent Development
Table 71. Episciences Company Details
Table 72. Episciences Business Overview
Table 73. Episciences Pigmentation Disorder Therapeutic Product
Table 74. Episciences Revenue in Pigmentation Disorder Therapeutic Business (2016-2021) & (US$ Million)
Table 75. Episciences Recent Development
Table 76. La Roche-Posay Company Details
Table 77. La Roche-Posay Business Overview
Table 78. La Roche-Posay Pigmentation Disorder Therapeutic Product
Table 79. La Roche-Posay Revenue in Pigmentation Disorder Therapeutic Business (2016-2021) & (US$ Million)
Table 80. La Roche-Posay Recent Development
Table 81. SkinCeuticals Company Details
Table 82. SkinCeuticals Business Overview
Table 83. SkinCeuticals Pigmentation Disorder Therapeutic Product
Table 84. SkinCeuticals Revenue in Pigmentation Disorder Therapeutic Business (2016-2021) & (US$ Million)
Table 85. SkinCeuticals Recent Development
Table 86. Pierre Fabre Company Details
Table 87. Pierre Fabre Business Overview
Table 88. Pierre Fabre Pigmentation Disorder Therapeutic Product
Table 89. Pierre Fabre Revenue in Pigmentation Disorder Therapeutic Business (2016-2021) & (US$ Million)
Table 90. Pierre Fabre Recent Development
Table 91. Alvogen Company Details
Table 92. Alvogen Business Overview
Table 93. Alvogen Pigmentation Disorder Therapeutic Product
Table 94. Alvogen Revenue in Pigmentation Disorder Therapeutic Business (2016-2021) & (US$ Million)
Table 95. Alvogen Recent Development
Table 96. Obagi Company Details
Table 97. Obagi Business Overview
Table 98. Obagi Revenue in Pigmentation Disorder Therapeutic Business (2016-2021) & (US$ Million)
Table 99. Obagi Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pigmentation Disorder Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. Pharmacological Treatment (Topical Drugs, Hydroquinone, L-Ascorbic Acid, etc.) Features
Figure 3. Cosmetic Treatment (Chemical Peel, Laser Therapy, Skin Grafting, etc.) Features
Figure 4. Global Pigmentation Disorder Therapeutic Market Share by Application: 2020 VS 2027
Figure 5. Dermatology Clinics Case Studies
Figure 6. Drugstores and Cosmetic Stores Case Studies
Figure 7. Aesthetic Clinics Case Studies
Figure 8. E-commerce Case Studies
Figure 9. Others Case Studies
Figure 10. Pigmentation Disorder Therapeutic Report Years Considered
Figure 11. Global Pigmentation Disorder Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Pigmentation Disorder Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Pigmentation Disorder Therapeutic Market Share by Regions: 2020 VS 2027
Figure 14. Global Pigmentation Disorder Therapeutic Market Share by Regions (2022-2027)
Figure 15. Global Pigmentation Disorder Therapeutic Market Share by Players in 2020
Figure 16. Global Top Pigmentation Disorder Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pigmentation Disorder Therapeutic as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Pigmentation Disorder Therapeutic Revenue in 2020
Figure 18. Global Pigmentation Disorder Therapeutic Revenue Market Share by Type (2016-2021)
Figure 19. Global Pigmentation Disorder Therapeutic Revenue Market Share by Type (2022-2027)
Figure 20. North America Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Pigmentation Disorder Therapeutic Market Share by Type (2016-2027)
Figure 22. North America Pigmentation Disorder Therapeutic Market Share by Application (2016-2027)
Figure 23. North America Pigmentation Disorder Therapeutic Market Share by Country (2016-2027)
Figure 24. United States Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Pigmentation Disorder Therapeutic Market Share by Type (2016-2027)
Figure 28. Europe Pigmentation Disorder Therapeutic Market Share by Application (2016-2027)
Figure 29. Europe Pigmentation Disorder Therapeutic Market Share by Country (2016-2027)
Figure 30. Germany Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Pigmentation Disorder Therapeutic Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Pigmentation Disorder Therapeutic Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Pigmentation Disorder Therapeutic Market Share by Region (2016-2027)
Figure 40. China Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Pigmentation Disorder Therapeutic Market Share by Type (2016-2027)
Figure 48. Latin America Pigmentation Disorder Therapeutic Market Share by Application (2016-2027)
Figure 49. Latin America Pigmentation Disorder Therapeutic Market Share by Country (2016-2027)
Figure 50. Mexico Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Pigmentation Disorder Therapeutic Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Pigmentation Disorder Therapeutic Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Pigmentation Disorder Therapeutic Market Share by Country (2016-2027)
Figure 56. Turkey Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Pigmentation Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Bayer Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2016-2021)
Figure 60. Allergan Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2016-2021)
Figure 61. Episciences Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2016-2021)
Figure 62. La Roche-Posay Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2016-2021)
Figure 63. SkinCeuticals Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2016-2021)
Figure 64. Pierre Fabre Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2016-2021)
Figure 65. Alvogen Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2016-2021)
Figure 66. Obagi Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---